Showing results (11-20 of 14) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Diabetes, Obesity & Metabolism|July 22, 2020
Benefit/risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2Chantal Mathieu, Paresh Dandona, Andreas L Birkenfeld, et al.American Journal of Nephrology|December 9, 2019
Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes MellitusDavid Z I Cherney, Enrico Repetto, David C Wheeler, et al.The Lancet. Diabetes & Endocrinology|September 18, 2020
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trialsPer-Henrik Groop, Paresh Dandona, Moshe Phillip, et al.Science Signaling|November 20, 2014
Combined inhibition of PI3Kβ and PI3Kγ reduces fat mass by enhancing α-MSH-dependent sympathetic driveAlessia Perino, Martina Beretta, Ana Kilić, et al.Pageof 2